XSVM - ETF AI Analysis
Top Page
Invesco S&P SmallCap Value with Momentum ETF (XSVM)
Rating:67Neutral
Price Target:―
Positive Factors
Solid Recent Performance
The ETF has shown steady gains over the past month, three months, and year to date, indicating positive recent momentum.
Strong Top Holdings Momentum
Many of the largest positions, such as American Axle, The Andersons, and StoneX Group, have delivered strong year-to-date performance, helping support the fund’s returns.
Focused Small-Cap Value With Momentum Strategy
The fund targets smaller companies that are both undervalued and showing positive price trends, which can offer attractive growth potential compared with the broader market.
Negative Factors
Heavy Financial Sector Concentration
With a large share of assets in financial stocks, the ETF is more exposed to risks specific to that sector than a more evenly balanced fund.
High U.S.-Only Exposure
Almost all holdings are in U.S. companies, so investors get little geographic diversification and remain highly tied to the U.S. economy.
Mixed Performance Among Top Holdings
A few key positions, including Kohl’s and G-III Apparel Group, have shown weak year-to-date performance, which can drag on overall returns if the weakness continues.
XSVM vs. SPDR S&P 500 ETF (SPY)
AUM590.49M
RegionNorth America
Expense Ratio0.37%
Beta0.87
IssuerInvesco
Inception DateMar 03, 2005
Dividend Yield1.91%
Asset ClassEquity
Index TrackedS&P SmallCap 600 High Momentum Value
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume24,758
30 Day Avg. Volume41,414
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
71.89Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering117
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
XSVM Summary
XSVM is an ETF that follows the S&P SmallCap 600 High Momentum Value Index, focusing on smaller U.S. companies that look cheap based on fundamentals but have recently been performing well. It holds a mix of sectors, with a lot in financial and consumer-related businesses, and includes names like Kohl’s and American Axle. Someone might invest in XSVM to seek higher growth potential from small companies and to diversify beyond large, well-known stocks. A key risk is that small-cap stocks can be very volatile, so the ETF’s price can move up and down sharply with the market.
How much will it cost me?The Invesco S&P SmallCap Value with Momentum ETF (XSVM) has an expense ratio of 0.37%, meaning you’ll pay $3.70 per year for every $1,000 invested. This cost is slightly higher than average for ETFs because it tracks a specialized index and uses a more active strategy to combine value and momentum investing. It’s designed for investors seeking targeted exposure to small-cap stocks with strong growth potential.
What would affect this ETF?XSVM’s focus on U.S. small-cap companies with strong value and momentum characteristics could benefit from economic growth and favorable consumer spending trends, especially in sectors like financials and consumer cyclical, which make up a significant portion of its holdings. However, the ETF may face challenges during periods of economic uncertainty or rising interest rates, which can negatively impact small-cap stocks and sectors like real estate and financials. Regulatory changes or shifts in market sentiment could also influence the performance of its top holdings.
XSVM Top 10 Holdings
XSVM is leaning hard into U.S. small-cap value, with financials in the driver’s seat and consumer-focused names riding shotgun. Par Pacific Holdings has been a clear bright spot, powering ahead and giving the fund some welcome momentum, while Scholastic and The Andersons are also rising steadily and helping to keep returns on track. On the flip side, Genworth Financial and Adient are losing steam, acting as small but noticeable drags. Overall, the fund is diversified across many industries but still feels distinctly financial- and consumer-heavy within the U.S. market.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| The Andersons | 1.80% | $10.65M | $2.53B | 96.83% | 71 Outperform | |
| StoneX Group | 1.72% | $10.17M | $7.31B | 84.45% | 58 Neutral | |
| United Natural Foods | 1.68% | $9.90M | $2.81B | 91.08% | 52 Neutral | |
| Marinemax | 1.60% | $9.47M | $597.60M | 43.85% | 51 Neutral | |
| Par Pacific Holdings | 1.44% | $8.49M | $3.11B | 359.85% | 67 Neutral | |
| AdaptHealth | 1.36% | $8.04M | $1.65B | 40.53% | 74 Outperform | |
| Dana Incorporated | 1.31% | $7.75M | $3.99B | 237.90% | 58 Neutral | |
| Scholastic | 1.29% | $7.64M | $857.52M | 141.43% | 60 Neutral | |
| Fresh Del Monte Produce | 1.27% | $7.50M | $2.03B | 35.46% | 69 Neutral | |
| Genworth Financial | 1.27% | $7.50M | $3.39B | 33.79% | 60 Neutral |
XSVM Technical Analysis
Positive
―
Price Trends
61.07
Positive
59.38
Positive
56.88
Positive
Market Momentum
0.66
Negative
66.77
Neutral
90.90
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For XSVM, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 59.98, equal to the 50-day MA of 61.07, and equal to the 200-day MA of 56.88, indicating a bullish trend. The MACD of 0.66 indicates Negative momentum. The RSI at 66.77 is Neutral, neither overbought nor oversold. The STOCH value of 90.90 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for XSVM.
XSVM Peer Comparison
Comparison Results
Performance Comparison
XSVM
Invesco S&P SmallCap Value with Momentum ETF
63.05
18.04
40.08%
OSCV
Opus Small Cap Value ETF
―
―
―
ISCV
iShares Morningstar Small Cap Value ETF
―
―
―
RZV
Invesco S&P Smallcap 600 Pure Value ETF
―
―
―
SVAL
iShares US Small Cap Value Factor ETF
―
―
―
TSCV
Thrivent Small Cap Value ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents